N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease

Journal of Nephrology

Volumn 10, Issue 3, 1997, Pages 157-162

  Cappelli, Paolo ^a,b   Di Liberato, Lorenzo ^a   Stuard, Stefano ^a   Ballone, Enzo ^a   Albertazzi, Alberto ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

Chronic renal failure; Cytokines; Immune abnormalities; Lipids; Polyunsaturated fatty acids; Progression of renal disease

Indexed keywords

CYTOKINE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIET SUPPLEMENTATION; DRUG EFFECT; FOLLOW UP; HUMAN; TREATMENT OUTCOME; URINARY EXCRETION;

ADULT; AGED; CYTOKINES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED;

EID: 0030876639     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33: 917-24.
2. Keane WF, Kasiske BL, O'Donnel MP. Lipids and progressive glomerulosclerosis: a model analogous to atherosclerosis. Am J Nephrol 1988; 8: 261-71.
3. Cappelli P, Evangelista M, Bonomini M, Palmieri PF, Albertazzi A. Lipids in the progression of chronic renal failure. Nephron 1992; 62: 31-5.
4. Samuelsson O, Aurell M, Knight-Gibson C, Alaupovic P, Attman P-O. Alipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 1993; 63: 279-85.
5. Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 1981; 19: 625-37.
6. Attman P-O, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991; 39 (Suppl 31): S16-23.
7. Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity. A critical survey. Kidney Int 1993; 43 (Suppl 41): S135-42.
8. Chatenoud L, Jungers P, Descamps-Latscha B. Immunological considerations of the uremic and dialyzed patient. Kidney Int 1994; 45 (Suppl 44): S92-96.
9. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438-63.
10. Harris WS. Fish oils and plasma lipid and lipoproteins metabolism in humans. A critical review. J Lipid Res 1989; 30: 785-807.
11. Schmidt EB, Kristensen SD, De Caterina R, Illingworth DR. The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 1993; 103: 107-21.
12. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-71.
13. Meydani SN, Endres S, Wood MM, et al. Oral n-3 fatty acid supplementation suppresses cytokine production and lymphocyte proliferation. Comparison in young and older women. J Nutr 1991; 121: 547-55.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
15. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Lab Invest 1968; 97: 77-9.
16. Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet 1994; 26: 16-43.
17. Biermann EL. Atherosclerosis and other forms of arteriosclerosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds): Harrison's Principles of Internal Medicine 13th ed. New York; McGraw-Hill 1994, pp 1106-16.
18. Hansson GK. Immune and inflammatory mechanism in the development of atherosclerosis. Br Heart J 1993; 69 (Suppl): S-38-41.
19. Dinarello CA. Cytokines: Agents provocateurs in hemodialysis? Kidney Int 1992; 41: 683-94.
20. Kaji T, Hyraga S, Yamamoto C. Tumor necrosis factor alpha-induced alteration of glycosaminoglycans in cultured vascular smooth-muscle cells. Bioch Bioph Acta 1993; 1176: 20-6.
21. Floege J, Grone H-J. Progression of renal failure: what is the role of cytokines? Nephrol Dial Transplant 1995; 10: 1575-86.
22. Herbelin A, Ureña P, Nguyen AT, Zingraff J, Descamps-Latscha B. Influence of first and long-term dialysis on uraemia-associated increased basal production of Interleukin-1 and Tumor Necorsis Factor α by circulating monocytes. Nephrol Dial Transplant 1991; 6: 349-57.
23. Donadio JV. Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clin Proc 1991; 66: 1018-28.
24. Nordoy A. Is there a rational use for n-3 fatty acids (fish oils) in clinical medicine? Drugs 1991; 42: 331-42.
25. Bilo HJG, Homan van der Heide JJ, Gans ROB, Donker AJM. Omega-3 polyunsaturated fatty acids in chronic renal insufficiency. Nephron 1991; 57: 385-93.
26. De Caterina R, Endres S, Kristensen SD, Schmidt EB. n-3 fatty acids and renal diseases. Am J Kidney Dis 1994; 24: 397-415.
27. De Caterina R, Caprioli R, Giannessi D, et al. n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 1993; 44: 843-50.